Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.3000
-0.0620 (-17.13%)
Jul 8, 2026, 1:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 28.77 million as of July 8, 2026. Its market cap has increased by 61.99% in one year.
Market Cap
28.77M
Enterprise Value
30.56M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 28.77M, a decrease of -70.30%. That is a compound annual growth rate of -18.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 28.77M | 187.26% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 116.43B |
| Coloplast | 91.53B |
| Demant | 58.17B |
| Gubra | 5.66B |
| BioPorto | 544.62M |
| Pharma Equity Group | 97.47M |
| ViroGates | 94.68M |